Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment [NA]
Clinical trial update on a PSMA and TARP peptide vaccine with a Poly IC-LC adjuvant in HLA-A2 positive patients with elevated PSA after defi…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer [Phase 2]
Phase 2 trial evaluating vitamin D and soy supplements for recurrent prostate cancer has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2014-02-12Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating stereotactic body radiotherapy with concurrent boost for low- and intermediate-risk prostate cancer has been withdr…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study) [Phase 3]
An update on a Phase 3 trial evaluating osteoporosis prevention in men with prostate cancer receiving androgen deprivation therapy. The stud…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only [Phase 3]
Phase 3 open-label extension updates for skeletal-related events in patients with bone metastases from prostate cancer and breast cancer (an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Proteases in Patients With Prostate Cancer That Has Spread to the Bone
This document reports the completion status of a clinical trial investigating proteases in patients with prostate cancer that has spread to …
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating the acute effects of exercise on the cortical silent period in prostate cancer patients has comp…
-
FDA approval · 2014-02-07FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ZYTIGA (abiraterone acetate) from Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer [Phase 2, Phase 3]
This clinical trial update describes the use of Ablatherm Integrated Imaging High Intensity Focused Ultrasound for low-risk, localized prost…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer [Phase 3]
Phase 3 randomized trial comparing docetaxel plus dasatinib vs docetaxel plus placebo in castration-resistant prostate cancer; results were …
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer [Phase 2]
Phase 2 trial evaluating docetaxel before radical prostatectomy in men with high-risk localized prostate cancer; results were posted in 2014…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer [Phase 1]
A Phase 1 study evaluating the maximum tolerated dose of Elesclomol Sodium when given with a fixed dose of Docetaxel and Prednisone in patie…
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer [Phase 2]
Phase 2 trial evaluating the combination of hormone therapy and ipilimumab in advanced prostate cancer; results have been posted after compl…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery [NA]
This clinical trial update describes using transrectal ultrasound to locate tumors during robotic-assisted laparoscopic surgery for prostate…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating a combination of goserelin, flutamide, and radiation therapy for locally advanced prostate cancer has comp…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate Cancer [NA]
This entry provides an update on a clinical trial evaluating MRI-TRUS fusion image-guided prostate biopsy after radical prostatectomy in men…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy [Phase 2]
This is a Phase 2 trial evaluating two itraconazole dose levels in metastatic prostate cancer patients whose disease progressed on hormonal …
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: The Effect of Dexmedetomidine in Intraocular Pressure During Robot-Assisted Laparoscopic Radical Prostatectomy [NA]
This completed clinical trial evaluated whether dexmedetomidine alters intraocular pressure during robot-assisted laparoscopic radical prost…
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Brachytherapy in Treating Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial update on the use of brachytherapy to treat prostate cancer.
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy
A Phase I trial tested MR spectroscopy-guided targeting of the dominant intraprostatic lesion with high-dose-rate brachytherapy in prostate …
-
CLINICAL_TRIALS research · 2014-01-22Clinical Trial Update: The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study
A retrospective study evaluates how different doses of remifentanil impact kidney function in patients undergoing robot-assisted prostatecto…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer [Phase 2]
A Phase II trial of TPI 287 for metastatic prostate cancer sponsored by Cortice Biosciences, Inc. has been terminated.
-
EMA withdrawal · 2014-01-21EMA Lapsed: Docetaxel Teva Pharma (docetaxel) — Teva Pharma B.V.
The EMA lists Docetaxel Teva Pharma as lapsed (withdrawn) for multiple indications including non-small cell lung carcinoma, breast neoplasms…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer [NA]
Clinical trial update reporting MRI and MR spectroscopy imaging in men taking dutasteride for benign prostatic hyperplasia and low-risk pros…
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer [Phase 2]
A Phase 2 clinical trial is evaluating capsaicin as a chemopreventive agent for prostate cancer.